MM

Mohammad Murtuja

Active Director Director DIN 08008082
DIN 08008082 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Mohammad Murtuja

Data last updated:

Mohammad Murtuja is a Director at Nettle Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Nettle Pharmaceuticals Private Limited reported revenue of ₹30,025 (FY 2024).

DIN 08008082
Primary Designation Director
Industry Pharma
First Appointment 15 Sep 2018
Oldest Company Age 14 yrs
Largest company Nettle Pharmaceuticals Private Limited · ₹30,025 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20182012₹30,025 (FY 2024)Active

Board colleagues of Mohammad Murtuja

NameDINCompanyDesignation
Ravi Ranjan Kumar08128648Nettle Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nettle Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohammad Murtuja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Murtuja

Mohammad Murtuja currently holds 1 directorship: Nettle Pharmaceuticals Private Limited (Director, since 15 Sep 2018, revenue ₹30,025 (FY 2024)).

Mohammad Murtuja was first appointed on 15 Sep 2018 as Director at Nettle Pharmaceuticals Private Limited.

The current boards of Mohammad Murtuja's companies include Ravi Ranjan Kumar (Nettle Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available